Trexquant Investment »

Crispr Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.3M 132k 62.60
2023-06-30 $2.0M 36k 56.14
2022-06-30 $305k 5.0k 60.74
2021-03-31 $1.3M 11k 121.88
2020-06-30 $447k 6.1k 73.42
2020-03-31 $2.0M 47k 42.41
2019-12-31 $3.3M 54k 60.90
2019-09-30 $425k 10k 41.01
2019-06-30 $466k 9.9k 47.07
2018-12-31 $1.6M 55k 28.58
2018-09-30 $250k 5.6k 44.38
2018-03-31 $522k 11k 45.75
2017-12-31 $429k 18k 23.46